Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy

BACKGROUND: Acquiring resistance to endocrine therapy is common in metastatic hormone-receptor-positive breast cancer (MBC). These patients most often transition either to next-line endocrine therapy or to systemic chemotherapy. However, withdrawal of endocrine therapy and observation as is selectiv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Cancer
Auteurs principaux: Chavarri-Guerra, Y, Higgins, M J, Szymonifka, J, Cigler, T, Liedke, P, Partridge, A, Ligibel, J, Come, S E, Finkelstein, D, Ryan, P D, Goss, P E
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2014
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260029/
https://ncbi.nlm.nih.gov/pubmed/25233398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.502
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires